Beneficial effect of aliskiren combined with olmesartan in reducing urinary protein excretion in patients with chronic kidney disease
Takahito Moriyama(Tokyo Women's Medical University), Kosaku Nitta(Tokyo Women's Medical University), Tetsuya Ogawa(Nihon University), Takashi Takei(Tokyo Women's Medical University), Mitsuyo Itabashi(Tokyo Women's Medical University), Hidekazu Sugiura(Tokyo Women's Medical University), Keiko Uchida(Tokyo Women's Medical University), Chiari Kojima(Tokyo Women's Medical University), Ken Tsuchiya(Tokyo Women's Medical University), Yuki Tsuruta(Tokyo Women's Medical University)
Cited by 21
Related Papers
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425
IP <sub>3</sub> Receptor Types 2 and 3 Mediate Exocrine Secretion Underlying Energy Metabolism
|Science|2005|317
M<sub>3</sub> muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice
|The Journal of Physiology|2004|191
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
|Renal Replacement Therapy|2020|170
Left Ventricular Hypertrophy Is Associated with Arterial Stiffness and Vascular Calcification in Hemodialysis Patients
|Hypertension Research|2004|161